Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-015449
Filing Date
2018-11-08
Accepted
2018-11-08 13:42:12
Documents
49
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 474438
2 ex31-1.htm EX-31.1 20867
3 ex31-2.htm EX-31.2 20759
4 ex32-1.htm EX-32.1 7451
  Complete submission text file 0001493152-18-015449.txt   2860832

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE ptix-20180930.xml EX-101.INS 469771
6 XBRL SCHEMA FILE ptix-20180930.xsd EX-101.SCH 36166
7 XBRL CALCULATION FILE ptix-20180930_cal.xml EX-101.CAL 37402
8 XBRL DEFINITION FILE ptix-20180930_def.xml EX-101.DEF 146980
9 XBRL LABEL FILE ptix-20180930_lab.xml EX-101.LAB 255136
10 XBRL PRESENTATION FILE ptix-20180930_pre.xml EX-101.PRE 207489
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51353 | Film No.: 181169159
SIC: 7389 Services-Business Services, NEC